Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-25-045295)

Filing Details

Accession Number:: 0000950170-25-045295
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-26 16:30:14
Reporting Period:: 2025-03-25

Filing Date:: 2025-03-26
Accepted Time:: 2025-03-26 16:30:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1563880	Trevi Therapeutics Inc.	TRVI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1229946	Thomas Sciascia	C/O Trevi Therapeutics, Inc. 195 Church Street, 16Th Floor New Haven CT 06510	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-25	2,631	$1.43	224,004	No	4	M	Direct
Common Stock	Disposition	2025-03-25	2,631	$6.60	221,373	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2025-03-25	2,631	$0.00	2,631	$1.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-05-14	No	4	M	Direct

Footnotes

Includes 1,058 shares purchased through the Issuer's employee stock purchase plan.
This option was granted on May 15, 2015. The 2,631 shares of common stock underlying the option vested as to 25% of the shares on May 15, 2016 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through May 15, 2019.